Martin Joseph Joyce - Net Worth and Insider Trading
Martin Joseph Joyce Net Worth
The estimated net worth of Martin Joseph Joyce is at least $147,397 dollars as of 2023-09-26. Martin Joseph Joyce is the Director of Aldeyra Therapeutics Inc and owns about 23,967 shares of Aldeyra Therapeutics Inc (ALDX) stock worth over $147,397. Details can be seen in Martin Joseph Joyce's Latest Holdings Summary section.
Transaction Summary of Martin Joseph Joyce
Martin Joseph Joyce Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Martin Joseph Joyce owns 2 companies in total, including Aldeyra Therapeutics Inc (ALDX) , and Caliber Imaging & Diagnostics Inc (LCDX) .
Click here to see the complete history of Martin Joseph Joyce’s form 4 insider trades.
Insider Ownership Summary of Martin Joseph Joyce
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 2016-06-09 | director |
| LCDX | Caliber Imaging & Diagnostics Inc | 2011-12-27 | Chief Financial Officer |
Martin Joseph Joyce Latest Holdings Summary
Martin Joseph Joyce currently owns a total of 1 stock. Martin Joseph Joyce owns 23,967 shares of Aldeyra Therapeutics Inc (ALDX) as of June 23, 2022, with a value of $147,397.
Latest Holdings of Martin Joseph Joyce
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 2022-06-23 | 23,967 | 6.15 | 147,397 |
Holding Weightings of Martin Joseph Joyce
Martin Joseph Joyce Form 4 Trading Tracker
According to the SEC Form 4 filings, Martin Joseph Joyce has made a total of 2 transactions in Aldeyra Therapeutics Inc (ALDX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Aldeyra Therapeutics Inc is the acquisition of 4,323 shares on June 23, 2022, which cost Martin Joseph Joyce around $15,044.
Insider Trading History of Martin Joseph Joyce
- 1
Martin Joseph Joyce Trading Performance
GuruFocus tracks the stock performance after each of Martin Joseph Joyce's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martin Joseph Joyce is 9.91%. GuruFocus also compares Martin Joseph Joyce's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martin Joseph Joyce within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Martin Joseph Joyce's insider trading performs compared to the benchmark.
Performance of Martin Joseph Joyce
Average Relative Return
53%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 12.57 | 9.91 | 3.17 | 53 | 23.05 | 1.85 |
| Relative Return to S&P 500(%) | 11.16 | 8.96 | 7.48 | 39.08 | 7.84 | -10.07 |
Martin Joseph Joyce Ownership Network
Ownership Network List of Martin Joseph Joyce
Ownership Network Relation of Martin Joseph Joyce
Martin Joseph Joyce Owned Company Details
What does Aldeyra Therapeutics Inc do?
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
Who are the key executives at Aldeyra Therapeutics Inc?
Martin Joseph Joyce is the director of Aldeyra Therapeutics Inc. Other key executives at Aldeyra Therapeutics Inc include See Remarks Bruce Greenberg , Chief Development Officer Stephen Machatha , and 10 percent owner Joseph Edelman .
Aldeyra Therapeutics Inc (ALDX) Insider Trades Summary
Over the past 18 months, Martin Joseph Joyce made 1 insider transaction in Aldeyra Therapeutics Inc (ALDX) with a net purchase of 4,323. Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net purchase of 1,305,206 shares made by Perceptive Life Sciences Master Fund Ltd , a net purchase of 17,700 shares made by Todd C Brady ,
In summary, during the past 3 months, insiders sold 0 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 1,327,229 shares were bought by its insiders, resulting in a net purchase of 1,327,229 shares.
Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aldeyra Therapeutics Inc Insider Transactions
Martin Joseph Joyce Mailing Address
Above is the net worth, insider trading, and ownership report for Martin Joseph Joyce. You might contact Martin Joseph Joyce via mailing address: 1050 Hingham Street, Rockland Ma 02370.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
